Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:45 pm Purchase | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 4,588,034 9.985% | 2,488,225 (+118.50%) | View |
| 2024-02-14 4:45 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | K2 HealthVentures Equity Trust LLC | 1,784,169 4% | 217,705 (+13.90%) | View |
| 2024-02-14 4:45 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | K2 HealthVentures Equity Trust LLC | 596,145 9.985% | 596,145 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | K2 HealthVentures Equity Trust LLC | 22,467,675 5.2% | 22,467,675 (New Position) | View |
| 2024-02-14 4:45 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.5% | 342,113 (New Position) | View |
| 2024-02-14 4:41 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.8% | 10,524,401 (New Position) | View |
| 2023-06-26 5:27 pm Purchase | 13G | MOLECULAR TEMPLATES INC MTEM | K2 HealthVentures Equity Trust LLC | 6,250,860 9.985% | 6,250,860 (New Position) | View |
| 2023-03-20 5:20 pm Purchase | 13G | ASLAN PHARMACEUTICALS LTD ADS ASLN | K2 HealthVentures Equity Trust LLC | 26,466,126 6.2% | 26,466,126 (New Position) | View |
| 2022-11-01 4:06 pm Purchase | 13G | ONCORUS INC ONCR | K2 HealthVentures Equity Trust LLC | 2,593,767 9.1% | 2,593,767 (New Position) | View |
| 2022-09-30 5:24 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | K2 HealthVentures Equity Trust LLC | 1,566,464 6.3% | 1,566,464 (New Position) | View |
| 2022-09-30 5:21 pm Purchase | 13G | TSCAN THERAPEUTICS INC TCRX | K2 HealthVentures Equity Trust LLC | 2,099,809 9.985% | 2,099,809 (New Position) | View |